Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
jeff67's Profile
Displaying 101-150 of 625 result(s).
CYDY CytoDyn Inc
06/22/2022 2:00:14 PM
True. i was an exec at a start up.. (1)
CYDY CytoDyn Inc
06/21/2022 6:59:57 PM
Laughable…no, you are incorrect. (2)
CYDY CytoDyn Inc
06/19/2022 6:23:46 PM
Dr Kelly , I dont believe, removed (3)
CYDY CytoDyn Inc
06/01/2022 4:10:01 PM
Could very well be 4-Good putting a (1)
CYDY CytoDyn Inc
05/12/2022 7:10:28 PM
The crying that the game is rigged (12)
CYDY CytoDyn Inc
05/10/2022 10:53:55 PM
Once that paper is peer reviewed it (2)
CYDY CytoDyn Inc
03/23/2022 10:28:26 AM
Not a big fan of the FDA but the B (7)
CYDY CytoDyn Inc
03/22/2022 10:53:48 AM
the biggest mystery of all the thi (2)
CYDY CytoDyn Inc
03/18/2022 10:06:18 AM
companies cannot survive long term (2)
CYDY CytoDyn Inc
03/17/2022 5:00:02 PM
I think you are spot on !
CYDY CytoDyn Inc
03/17/2022 4:57:22 PM
all deals whether a partnership or (1)
CYDY CytoDyn Inc
03/17/2022 11:27:45 AM
Ive dealt with 5 acquisitions of co (4)
CYDY CytoDyn Inc
03/15/2022 12:23:01 PM
Not when the PRs were prolific and (7)
CYDY CytoDyn Inc
03/03/2022 8:50:26 AM
there is no reason that an NDA woul (3)
CYDY CytoDyn Inc
03/01/2022 11:50:57 AM
as much as i would like to see that (2)
CYDY CytoDyn Inc
02/24/2022 9:03:49 AM
The company is being managed by law (5)
CYDY CytoDyn Inc
02/21/2022 5:02:06 PM
There really isnt a "marketing ment (5)
CYDY CytoDyn Inc
02/20/2022 7:08:39 PM
I wouldn’t be surprised if 4-good (11)
CYDY CytoDyn Inc
02/17/2022 6:02:19 PM
I mentioned this scenario either on (1)
CYDY CytoDyn Inc
02/16/2022 2:16:54 PM
i would agree with your position e (4)
CYDY CytoDyn Inc
02/15/2022 7:54:04 PM
going the opposite in my mind..part (2)
CYDY CytoDyn Inc
02/14/2022 12:23:07 PM
its quite possible there is an NDA (3)
CYDY CytoDyn Inc
02/09/2022 6:37:54 PM
thanks melsdollars for the update. (2)
CYDY CytoDyn Inc
02/09/2022 2:40:23 PM
very strong homework there. the onl (1)
CYDY CytoDyn Inc
02/09/2022 10:43:08 AM
Part that and perhaps because his p (2)
CYDY CytoDyn Inc
02/08/2022 11:11:11 PM
If the company truly formed the 3 p
CYDY CytoDyn Inc
02/07/2022 2:02:34 PM
the door is still open for selling (1)
CYDY CytoDyn Inc
01/31/2022 5:01:09 PM
sure its all speculation but my bel (2)
CYDY CytoDyn Inc
01/31/2022 10:43:38 AM
when an exec loses their job , they (5)
CYDY CytoDyn Inc
01/30/2022 12:43:53 PM
I still believe the best shot at in (1)
CYDY CytoDyn Inc
01/30/2022 12:26:31 PM
I would say one of the key reasons (4)
CYDY CytoDyn Inc
01/29/2022 10:30:27 AM
I think its more like a process of (12)
CYDY CytoDyn Inc
01/28/2022 1:31:35 PM
without cause with cause in this ca (1)
CYDY CytoDyn Inc
01/27/2022 9:06:44 AM
remember , NY has been over represe (4)
CYDY CytoDyn Inc
01/26/2022 9:32:14 PM
thats fair but when there is a lead (4)
CYDY CytoDyn Inc
01/26/2022 7:37:40 PM
Since the company strategy was NPs, (2)
CYDY CytoDyn Inc
01/25/2022 7:04:58 PM
was a 'C' level for half my career (12)
CYDY CytoDyn Inc
01/18/2022 4:26:50 PM
there have been times we have had a (1)
CYDY CytoDyn Inc
01/15/2022 9:45:26 AM
doesnt work that way NSF owns all t (3)
CYDY CytoDyn Inc
01/15/2022 9:44:28 AM
being a part of 6 acquisitions in m (5)
CYDY CytoDyn Inc
01/13/2022 6:11:00 PM
they did postpone it. they said it
CYDY CytoDyn Inc
01/13/2022 6:03:53 PM
agree there are a lot of great rumo (1)
CYDY CytoDyn Inc
01/13/2022 10:54:15 AM
hysterical ! . im going with Amarex (1)
CYDY CytoDyn Inc
01/12/2022 9:58:06 AM
NP needs tro be front and center ex
CYDY CytoDyn Inc
01/11/2022 12:57:17 PM
i think its primarily focused on th (3)
CYDY CytoDyn Inc
01/10/2022 6:49:22 PM
225k in A/R and 225k in revenue so (1)
CYDY CytoDyn Inc
01/08/2022 10:27:34 AM
not staying on top of the survival
CYDY CytoDyn Inc
01/08/2022 10:19:17 AM
Covid isnt our nearest path to rev (4)
CYDY CytoDyn Inc
01/06/2022 2:49:28 PM
My belief is he did know based on a (5)
CYDY CytoDyn Inc
01/06/2022 8:48:58 AM
I agree....if we follow in the foot (4)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Neogen Corporation Investors Can Join Class Action Efforts
  • Key Actions for Luminar Technologies Investors Amid Class Action
  • Investors Urged to Act: RxSight Class Action Deadline Approaches
  • Sable Offshore Corp. Class Action: Important Actions for Investors
  • Protecting Your Rights Following Securities Claims with TRSG
  • Investors of Fiserv, Inc. Can Join Class Action for Losses
  • Kepler's K2 Humanoid Robot Revolutionizes Industrial Automation
  • Investor Rights Firm Investigates Potential Mergers and Sales
  • Investigating Stockholder Rights: Olo, Fubo, Arcadia, and Norfolk
  • RxSight Inc. Faces Class Action Lawsuit Over Misleading Claims
  • Spitzer Autoworld Elevates Customer Experience with New VIP Program
  • HashJ Launches New BTC Participation Contracts Amid Market Shift
  • Experience Vibrant Music Events at Great Park Live This Season
  • Explore OLIVE YOUNG's K-Beauty Innovations at KCON LA 2025
  • Discovering the Exceptional Growth of Gartner Stock Today
  • Investors of Sable Offshore Corp. Encouraged to File Claims
  • Senate Bill Secures Funding for OSHA and NIOSH - A Win for Safety
  • Arteris, Inc. Boosts Team with New Inducement Stock Awards
  • Investing in Ameriprise Financial: A 5-Year Review
  • Grupo Cox Makes Major Investment with Iberdrola Acquisition
  • First National Bank Alaska Announces Strong Q3 Dividend Strategy
  • Understanding the Long-Term Value of American Express Stock
  • First National Bank Alaska Announces Third Quarter Dividend
  • Project 61 and Offshift Join Forces for Truck Driver Health
  • Keg Royalties Income Fund Secures Approval for Fairfax Deal
  • The Keg Royalties Income Fund Secures Approval for Key Deal
  • Unlocking the Wealth from Shopify: 15 Years of Growth Insights
  • Lara's Rate Hikes: Consumers Left in Uncertainty Amid Secrecy
  • Barrett-Jackson Holdings Responds to Customer Data Breach
  • A Decade of Growth: $100 in Live Nation Entertainment's Journey
  • Crypto Market Surges—Will the Bull Momentum Continue?
  • Hims & Hers: A Bright Future Amidst Market Challenges
  • OZAK AI Raises $1.5M in Presale, Captivating AI Investors
  • Investigation into Corporate Governance of Key Companies
  • How A Small Investment In McKesson Grew Over 5 Years
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site